A novel acenocoumarol pharmacogenomic dosing algorithm for the Greek population of EU-PACT trial.

about

A novel acenocoumarol pharmacogenomic dosing algorithm for the Greek population of EU-PACT trial.

Item

http://www.wikidata.org/entity/Q40425835

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

A novel acenocoumarol pharmaco ...... k population of EU-PACT trial.

@en

type

Item

label

A novel acenocoumarol pharmaco ...... k population of EU-PACT trial.

@en

prefLabel

A novel acenocoumarol pharmaco ...... k population of EU-PACT trial.

@en

P1476

A novel acenocoumarol pharmaco ...... ek population of EU-PACT trial

@en

P2093

Anke H Maitland-van der Zee

http://www.w3.org/2001/XMLSchema#string

Anna Tavridou

http://www.w3.org/2001/XMLSchema#string

Dimitrios Tziakas

http://www.w3.org/2001/XMLSchema#string

Genovefa Kolovou

http://www.w3.org/2001/XMLSchema#string

Georgia Ragia

http://www.w3.org/2001/XMLSchema#string

Stavros Konstantinides

http://www.w3.org/2001/XMLSchema#string

Vana Kolovou

http://www.w3.org/2001/XMLSchema#string

Vangelis G Manolopoulos

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacogenetic-guided dosing of coumarin anticoagulants: algorithms for warfarin, acenocoumarol and phenprocoumon

Therapeutic dosing of acenocoumarol: proposal of a population specific pharmacogenetic dosing algorithm and its validation in north Indians

A New Pharmacogenetic Algorithm to Predict the Most Appropriate Dosage of Acenocoumarol for Stable Anticoagulation in a Mixed Spanish Population

An acenocoumarol dosing algorithm using clinical and pharmacogenetic data in Spanish patients with thromboembolic disease.

Pharmacogenetic versus clinical dosing of warfarin in individuals of Chinese and African-American ancestry: assessment using data simulation.

Loading and maintenance dose algorithms for phenprocoumon and acenocoumarol using patient characteristics and pharmacogenetic data.

Genetic determinants of response to warfarin during initial anticoagulation

Factors affecting the maintenance dose of warfarin.

Association of functional VKORC1 promoter polymorphism with occurrence and clinical aspects of ischemic stroke in a Greek population.

Olive oil and haemostasis: platelet function, thrombogenesis and fibrinolysis.

P304

23-34

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/PGS-2016-0126

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Efstratios Maltezos

P577

2016-12-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27967328

http://www.w3.org/2001/XMLSchema#string

P921

pharmacogenomics